Published October 2000 | Version v1
Report Restricted

Modeling and optimization of tissue 10B concentration and dosimetry for arbitrary BPA-F infusion schedules in humans

  • 1. Massachusetts Institute of Technology, Nuclear Reactor Laboratory, MA (United States)
  • 2. Harvard Medical School, Beth Israel Deaconess Medical Center, Department of Radiology, Boston, MA (United States)

Description

Separate compartmental models have been derived for the concentration of 10B resulting from BPA-F infusion in the central vascular space (i.e., blood or, more appropriately, plasma) and in glioblastoma multiforme and normal brain. By coupling the model for the temporal variation of 10B concentration in the central vascular space with that for tissue, the dynamic behavior of the 10B concentration and the resulting dosimetry in the relevant tissues and blood may be predicted for arbitrary infusion schedules. This coupled model may be used as a tool for identifying the optimal time for BNCT irradiation and optimal BPA-F infusion schedule (i.e., temporal targeting) in humans without the need for expensive and time-consuming pharmacokinetic studies for every infusion schedule considered. This model was used to analyze the concentration profiles resulting from a wide range of infusion schedules and their implications for dosimetry. (author)

Files

Restricted

The record is publicly accessible, but files are restricted to users with access.

Part of:
Proceedings of the ninth international symposium on neutron capture therapy for cancer

Additional details

Publishing Information

Imprint Title
Proceedings of the ninth international symposium on neutron capture therapy for cancer
Imprint Pagination
369 p.
Journal Page Range
p. 183-184
Report number
KURRI-KR--54

Conference

Title
9. international symposium on neutron capture therapy for cancer
Dates
2-6 Oct 2000
Place
Osaka (Japan)

Optional Information

Notes
5 refs., 2 figs.